We are live on ! Find out more
TI

Telemetry Investments Portfolio holdings

AUM $63.3M
1-Year Est. Return 0.06%
This Fund
S&P 500
This Quarter Est. Return
+13.28%
1 Year Est. Return
+0.06%
3 Year Est. Return
+77.42%
5 Year Est. Return
+156.79%
10 Year Est. Return
AUM
$46M
AUM Growth
+$9.19M
Cap. Flow
+$8.51M
Cap. Flow %
18.49%
Top 10 Hldgs %
32.93%
Holding
84
New
19
Increased
17
Reduced
19
Closed
11

Sector Composition

Rank Sector Weight
1 Healthcare 27.81%
2 Financials 12.76%
3 Technology 5.51%
4 Communication Services 5.04%
5 Consumer Discretionary 2.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WUBA
76
DELISTED
58.com Inc
WUBA
-4,384
Closed -$236K
LOGM
77
DELISTED
LogMein, Inc.
LOGM
-6,000
Closed -$509K
ROSEW
78
DELISTED
Rosehill Resources Inc.
ROSEW
-35,960
Closed -$2K
LM
79
DELISTED
Legg Mason, Inc.
LM
-14,769
Closed -$735K
ROSE
80
DELISTED
Rosehill Resources Inc. Class A
ROSE
-63,137
Closed -$46K
ELGX
81
DELISTED
Endologix Inc
ELGX
-78,460
Closed -$63K
MEET
82
DELISTED
The Meet Group, Inc. Common Stock
MEET
-17,000
Closed -$106K
CBB
83
DELISTED
Cincinnati Bell Inc.
CBB
-12,325
Closed -$183K
EE
84
DELISTED
El Paso Electric Company
EE
-11,700
Closed -$784K

Similar funds

Telemetry Investments's Q3 2020 Portfolio in Review

As of Q3 2020, Telemetry Investments held 84 positions worth $46M, up 25% from $36.8M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Telemetry Investments deployed $8.51M of net new capital in Q3 2020, opening 19 new positions and adding to 17 existing holdings. Its largest new stake was Varian Medical Systems, Inc.: 10,300 shares worth $1.77M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 28% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Aclaris Therapeutics, an estimated $462K trimmed.

  • Telemetry Investments's largest Q3 2020 buy was Varian Medical Systems, Inc.: 10,300 shares worth $1.77M.
  • Telemetry Investments added most to Willis Towers Watson in Q3 2020, an estimated $1.45M increase.
  • Telemetry Investments's biggest Q3 2020 reduction was Aclaris Therapeutics, cutting an estimated $462K.
  • Telemetry Investments fully exited El Paso Electric Company in Q3 2020, selling an estimated $784K.
  • Telemetry Investments's ten largest holdings make up 33% of its $46M portfolio in Q3 2020.
  • Telemetry Investments opened 19 new positions and closed 11 in Q3 2020.
  • Telemetry Investments's portfolio value rose 25% quarter-over-quarter to $46M.

Based on Telemetry Investments's 13F filing for Q3 2020, filed 16 Nov 2020.